This company is an underappreciated coronavirus stock loaded with potential, according to one analyst who just initiated coverage of it. And even if its coronavirus… Read More »This Underappreciated Coronavirus Stock Is No One-Trick Pony
It’s no easy feat for a company to have been able to increase its dividend for at least 50 years in a row – through… Read More »The Latest Dividend Kings – And Some Potential Kings-In-Waiting
After initially being negatively impacted by the pandemic, several MedTech stocks are now benefitting from developments related to the crisis. Given COVID’s mixed impact on… Read More »After Several Mixed Months For MedTech Stocks, What’s The Best Strategy Now?
The canceling and postponing of surgical procedures during the COVID-19 lockdowns caused some pain for medical device companies. But now that procedure volumes are rising,… Read More »The Best Medical Device Plays As Procedure Volumes Recover
Whether it’s for COVID-19 or any other disease or disorder, there’s one key number that investors need to focus on when it comes to study… Read More »The Key Number To Study In Vaccine Study Results
With buy-and-hold investing not exactly appealing right now, and day trading a risky endeavor, is dividend investing the way to go in today’s COVID-stricken market?… Read More »In This COVID-Stricken Market, Go Long – And Abroad – On Dividend Stocks
More companies have lowered or suspended their dividends in the past 60 to 90 days than all the announced dividend cuts over the past 10… Read More »20 Companies To Boldly Go And Raise Their Dividends As The Recession Hit